Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases

NAActive, not recruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

July 22, 2025

Study Completion Date

July 22, 2027

Conditions
Metastatic Breast CancerMetastatic Lung CancerMetastatic Prostate CancerBone Metastases
Interventions
RADIATION

SBRT

SBRT will be added to systemic (standard) treatment of bone metastases.

Trial Locations (28)

Unknown

ICO - Site Paul Papin, Angers

Centre Marie Curie, Arras

Hôpital Privé Les Bonnettes, Arras

Institut Sainte Catherine, Avignon

Centre Pierre Curie, Beuvry

Clinique Ambroise Pare, Beuvry

Clinique Tivoli Ducos, Bordeaux

Institut Bergonié, Bordeaux

Hôpital Métropole Savoie, Chambéry

Pôle Leonard de Vinci, Chambray-lès-Tours

Centre Amethyst CROM, Creil

Hôpital Henri Mondor, Créteil

Centre Léonard de Vinci, Dechy

Institut de Cancérologie de Bourgogne, Dijon

Chu Grenoble, Grenoble

Centre Oscar Lambret, Lille

Hôpital Privé Le Bois, Lille

Centre Léon Bérard, Lyon

Institut Paoli Calmettes, Marseille

Centre de Cancérologie du Grand Montpellier, Montpellier

Institut de Cancérologie de Lorraine, Nancy

Institut de Cancérologie de l'Ouest, Nantes

Centre Catalan D'Oncologie, Perpignan

Institut Jean Godinot, Reims

Centre Henri Becquerel, Rouen

Centre d'oncologie et radiothérapie Saint-Jean, Saint-Doulchard

GCS RISSA - Institut de cancérologie Paris Nord, Sarcelles

Clinique des dentellières, Valenciennes

All Listed Sponsors
lead

UNICANCER

OTHER

NCT03143322 - Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases | Biotech Hunter | Biotech Hunter